Following Sarepta Therapeutics, Inc.?
Get the free weekly contract digest
The latest new contracts, like Sarepta Therapeutics, Inc.’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Sarepta Therapeutics Partners with Arrowhead Pharmaceuticals for siRNA Programs
Nov 26, 2024•over 1 year ago
Contract Type
partnership
CambridgeBiotechnologyHealthcareHealth CareTherapeuticsDescription
Sarepta Therapeutics has announced an exclusive global licensing and collaboration agreement with Arrowhead Pharmaceuticals, Inc. The agreement will add to Sarepta’s pipeline for rare, genetic diseases of the muscle, central nervous system (CNS), and the lungs.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months